Citation Impact
Citing Papers
Genetic-related and carbohydrate-related factors affecting liver fat accumulation
2012
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism
2016
Cell type-selective secretome profiling in vivo
2020 StandoutNobel
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
2013
Bardoxolone methyl: drug development for diabetic kidney disease
2020
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Regulation and Functions of the ER-Associated Nrf1 Transcription Factor
2022 StandoutNobel
MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels
2016
Hepatic Fat Accumulation Is Modulated by the Interaction between the rs738409 Variant in the PNPLA3 Gene and the Dietary Omega6/Omega3 PUFA Intake
2012
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Protective effects of GH and IGF-I against iron-induced lipid peroxidation in vivo
2008
Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children
2016 Standout
The prenatal origins of lung cancer. I. The fetus
2010
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
2000 Standout
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols
2021 StandoutNobel
Modulation of hepatic steatosis by dietary fatty acids
2014
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Limited value of routine microalbuminuria assessment in multi-ethnic obese children
2013
Metabolic syndrome, diabetes, and hyperuricemia
2013
Non-alcoholic fatty liver disease
2021 Standout
The genetics of NAFLD
2013
Long-term vitamin E supplementation reduces atherosclerosis and mortality in Ldlr−/− mice, but not when fed Western style diet
2014
Type 2 diabetes
2017 Standout
Inflammasomes: mechanism of assembly, regulation and signalling
2016 Standout
Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease
2016
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Association between Oxidative Stress and Masked Hypertension in a Multi-Ethnic Population of Obese Children and Adolescents
2010
Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis
2012
Genetics and epigenetics of NAFLD and NASH: Clinical impact
2017
Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis
2017
Association between maternal gluten intake and type 1 diabetes in offspring: national prospective cohort study in Denmark
2018
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Type 2 diabetes mellitus
2015 Standout
Energy Metabolism in the Liver
2014 Standout
Molecular aspects of fructose metabolism and metabolic disease
2021
Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
2018
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
2014
Metabolic memory in diabetes – from in vitro oddity to in vivo problem: Role of Apoptosis
2009
Management of metabolic syndrome in children and adolescents
2011
Oxidative Stress: Harms and Benefits for Human Health
2017 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Ethnic differences regarding arterial stiffness of 6‐8‐year-old black and white boys
2017
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
2003 Standout
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
Adipocyte-specific deficiency of Nfe2l1 disrupts plasticity of white adipose tissues and metabolic homeostasis in mice
2018
Childhood Disadvantage and Health Problems in Middle and Later Life
2015 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Vitamin E Inadequacy in Humans: Causes and Consequences
2014
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes
2019
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
2021
Caspase-12, but Not Caspase-11, Inhibits Obesity and Insulin Resistance
2015
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Potential role of Toll-like receptors in programming of vascular dysfunction
2013
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Youth With Obesity and Obesity-Related Type 2 Diabetes Mellitus Demonstrate Abnormalities in Carotid Structure and Function
2009
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
2017
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
β-Cell Function, Incretin Effect, and Incretin Hormones in Obese Youth Along the Span of Glucose Tolerance From Normal to Prediabetes to Type 2 Diabetes
2014
Triglyceride to HDL-C Ratio and Increased Arterial Stiffness in Children, Adolescents, and Young Adults
2013
Thyroid Hormone Regulation of Metabolism
2014 Standout
Synthesis of an organoinsulin molecule that can be activated by antibody catalysis
2001 StandoutNobel
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients
2019
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
The initiation of metabolic inflammation in childhood obesity
2017
Expanding Treatment Options for Youth With Type 2 Diabetes: Current Problems and Proposed Solutions
2016
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
2013 Standout
Review article: the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitis
2020
Prospectively Determined Impact of Type 1 Diabetes on Brain Volume During Development
2011
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle
2015 StandoutNobel
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Cosimo Giannini being referenced
Implications for kidney disease in obese children and adolescents
2011
Alterations in the oxidant‐antioxidant status in prepubertal children with growth hormone deficiency: effect of growth hormone replacement therapy
2005
Macrovascular angiopathy in children and adolescents with type 1 diabetes
2011
Variant in the glucokinase regulatory protein ( GCKR ) gene is associated with fatty liver in obese children and adolescents
2011
Obese related effects of inflammatory markers and insulin resistance on increased carotid intima media thickness in pre-pubertal children
2007
The possible role of liver steatosis in defining metabolic syndrome in prepubertal children
2009
A low disposition index in adolescent offspring of mothers with gestational diabetes: a risk marker for the development of impaired glucose tolerance in youth
2014
Effects of high‐dose vitamin E supplementation on oxidative stress and microalbuminuria in young adult patients with childhood onset type 1 diabetes mellitus
2007
Increased concentrations of soluble CD40 ligand may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria
2008
Macroangiopathy in Adults and Children with Diabetes: From Molecular Mechanisms to Vascular Damage (Part 1)
2006
Increased carotid intima-media thickness in pre-pubertal children with constitutional leanness and severe obesity: the speculative role of insulin sensitivity, oxidant status, and chronic inflammation
2009
Could Receptors for Advanced Glycation End Products Be Considered Cardiovascular Risk Markers in Obese Children?
2012
Oxidized Fatty Acids: A Potential Pathogenic Link Between Fatty Liver and Type 2 Diabetes in Obese Adolescents?
2013
What Is the Significance of Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products in Liver Steatosis in Obese Prepubertal Children?
2010
Circulating Levels of FGF-21 in Obese Youth: Associations With Liver Fat Content and Markers of Liver Damage
2013
Evidence for Early Defects in Insulin Sensitivity and Secretion Before the Onset of Glucose Dysregulation in Obese Youths
2012
The Triglyceride-to-HDL Cholesterol Ratio
2011
Insulin Resistance and Oxidative Stress in Children Born Small and Large for Gestational Age
2009
Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E
2012
Serum Levels of Receptors for Advanced Glycation End Products in Normal-Weight and Obese Children Born Small and Large for Gestational Age
2012
A Role of the Inflammasome in the Low Storage Capacity of the Abdominal Subcutaneous Adipose Tissue in Obese Adolescents
2015
Increased Oxidative Stress in Prepubertal Children Born Small for Gestational Age
2007
Weight Gain and Insulin Resistance in Children Treated With Valproate: The Influence of Time
2010
Decreased Transcription of ChREBP-α/β Isoforms in Abdominal Subcutaneous Adipose Tissue of Obese Adolescents With Prediabetes or Early Type 2 Diabetes
2012